As expected...jumping back close to 50s now... However, the elephant in the room now is... "Whatever happened to Paul Lapstun?" No clarification in this update..Hmm...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025